Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues

International Journal of Cancer

Volumn 83, Issue 2, 1999, Pages 210-214

  Mutirangura, Apiwat ^a   Charuruks, Navapun ^a   Shuangshoti, Shanop ^a   Sakdikul, Sairoong ^a   Chatsantikul, Rattana ^a   Pornthanakasem, Wichai ^a   Sriuranpong, Virote ^a   Supiyaphun, Pakpoom ^a   Voravud, Narin ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 13Q; DNA DETERMINATION; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; NASOPHARYNX CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; DNA, NEOPLASM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PARAFFIN EMBEDDING; RETINOBLASTOMA PROTEIN;

EID: 0032852463     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991008)83:2<210::AID-IJC11>3.0.CO;2-Y     Document Type: Article

References (28)

1. BARRETT, M.T., REID, B.J., and JOSLYN, G., Genotypic analysis of multiple loci in somatic cells by whole genome amplification. Nucleic Acids Res., 23, 3488-3492 (1995).
2. BROWN, A.G., ROSS, F.M., DUNNE, E.M., STEEL, C.M., and WEIR-THOMPSON, E.M., Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nature (Genet.), 3, 67-72 (1993).
3. COOMBES, M.M., MAO, L., STECK, K.D., LUNA, M.A., and EL-NAGGAR, A.K., Genotypic analysis of flow-sorted and microdissected head and neck squamous lesions by whole genome amplification. Diagn. mol. Pathol., 7, 197-201 (1998)
4. COONEY, K.A., WETZEL, J.C ., MERAJVER, S.D., MACOSKA, J.A., SINGLETON, T.P., and WOJNO, K.J., Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res., 5, 1142-1145 (1996).
5. CORCORAN, M.M. and 18 OTHERS, Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood. 4, 1382-1390 (1998).
6. DUDDY, S.K., GOROSPE, S., and BLEAVINS, MR., Genetic analysis of multiple loci in microsamples of fixed paraffin-embedded tissue. Toxicol Sci., 46, 317-323 (1998).
7. FANDI, A., ALTUN, M., AZLI, N., ARMAND, JP., and CVITKOVIC, E., Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin. Oncol., 3, 382-397(1994).
8. GULLEY, M.L., NICHOLLS, J.M., SCHNEIDER, B.G., AMIN, M.B., RO, J.Y., and GERADTS, J., Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. Amer. J. Pathol., 4, 865-869 (1998).
9. HAMANN, U., HERBOLD, C., COSTA, S., SOLOMAYER, E.F., KAUFMANN, M., BASTERT, G., ULMER, H.U., FRENZEL, H., and KOMITOWSKI, D., Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. Cancer Res., 9, 1988-1990 (1996).
10. HU, L.F., EIRIKSDOTTIR, G., LEBEDEVA, T., KHOLODNIOUK, I., ALIMOV, A., CHEN, F., LUO, Y., ZABAROVSKY, E.R., INGVARSSON, S., KLEIN, G., and ERNBERG, I., Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma. Genes Chromosomes Cancer, 2, 118-126 (1996).
11. HUANG, D.P., LO, K.W., VAN HASSELT, C.A., WOO, J.K., CHOI, PH., LEUNG, S.F., CHEUNG, S.T., CAIRNS, P., SIDRANSKY, D., and LEE, J.C., A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res., 15, 4003-4006 (1994).
12. HUI, A.B., LO, K.W., LEUNG, S.F., CHOI, P.H., FONG, Y., LEE, J.C., and HUANG, D.P., Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res., 14, 3225-3229 (1996).
13. KUROKI, T., FUJIWARA, Y., NAKAMORI, S., IMAOKA, S., KANEMATSU, T., and NAKAMURA, Y., Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Brit. J. Cancer, 2, 383-385 (1995).
14. LEE, W.H., BOOKSTEIN, R., HONG, F., YOUNG, L.J., SHEW, J.Y., and LEE, E.Y., Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science, 4794, 1394-1399 (1987).
15. LI, C., LARSSON, C., FUTREAL, A., LANCASTER, J., PHELAN, C., ASPENBLAD, U., SUNDELIN, B., LIU, Y., EKMAN, P., AUER, G., and BERGERHEIM, U.S., Identification of two distinct deleted regions on chromosome 13 in prostate cancer. Oncogene, 4, 481-487 (1998).
16. LIEBOWITZ, D., Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin. Oncol., 3, 376-381(1994).
17. LO, K.W., TSANG, Y.S., HUI, A.B.Y., CHEUNG, S.T., LEE, J.C.K., and HUANG, D.P., Aberrant methylation of 5′ CpG island of the endothelin B receptor gene and deletion of 13q in nasopharyngeal carcinoma. Proc. Amer. Assoc. Cancer Res., 40, 2918 (1999).
18. MAESTRO, R., PICCININ, S., DOGLIONI, C., GASPAROTTO, D., VUKOSAVLJEVIC, T., SULFARO, S., BARZAN, L., and BOIOCCHI, M., Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res., 5, 1146-1150(1996).
19. MOSKALUK, C.A., and KERN, S.E., Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Amer. J. Pathol., 5, 1547-1552 (1997).
20. MUTIRANGURA, A., PORNTHANAKASEM, W., SRIURANPONG, V., SUPIYAPHUN, P., and VORAVUD, N., Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma. Int. J. Cancer, 2, 153-156 (1998).
21. MUTIRANGURA, A., TANUNYUTTHAWONGESE, C., PORNTHANAKASEM, W., KEREKHANJANARONG, V., SRIURANPONG, V., YENRUDI, S., SUPIYAPHUN, P., and VORAVUD, N., Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Brit. J. Cancer, 6, 770-776 (1997).
22. NAWROZ-DANISH H.M., KOCH, W.M., WESTRA, W.H., YOO, G., and SIDRANSKY, D., Lack of BRCA2 alterations in primary head and neck squamous cell carcinoma. Otolaryngol. Head Neck Surg., 119, 21-25 (1998).
23. OGAWARA, K., MIYAKAWA, A., SHIBA, M., UZAWA, K., WATANABE, T., WANG, X.L., SATO, T., KUBOSAWA, H., KONDO, Y., and TANZAWA, H., Allelic loss of chromosome 13q14.3 in human oral cancer: correlation with lymph node metastasis. Int. J. Cancer, 4, 312-317 (1998).
24. SIKKINK, S.K., REHMAN, I., and REES, J.L., Deletion mapping of chromosome 3p and 13q and preliminary analysis of the FHIT gene in human nonmelanoma skin cancer. J. invest. Dermatol., 6, 801-805 (1997).
25. TAMURA, K., ZHANG, X., MURAKAMI, Y., HIROHASHI, S., XU, H.J., HU, S.X., BENEDICT, W.F., and SEKIYA, T., Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int. J. Cancer, 1, 45-49 (1997).
26. TELENIUS, H., CARTER, N.P., BEBB, C.E., NORDENSKJOLD, M., PONDER, B.A., and TUNNACLIFFE, A., Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics, 3, 718-725 (1992).
27. VORAVUD, N., Cancer in the far East. In: K. Sikora, and K.E. Halman (eds.), Treatment of cancer, (2nd ed.), pp.887-894. Chapman and Hall, London (1990).
28. WOOSTER, R., BIGNELL, G., LANCASTER, J., SWIFT, S., SEAL, S., MANGION, J., COLLINS, N., GREGORY, S., GUMBS, C., and MICKLEM, G., Identification of the breast cancer susceptibility gene BRCA2. Nature (Lond.), 6559, 789-792 (1995).